Fresenius Medical Care Production (Australia) Pty Ltd Summary

[2023] FWCA 485

FAIR WORK COMMISSION

DECISION

Fair Work Act 2009

s.185—Enterprise agreement

Fresenius Medical Care Production (Australia) Pty Ltd

(AG2023/153)

Fresenius Medical Care Smithfield Production, Manufacturing & Supply Chain Enterprise Agreement 2023

Manufacturing and associated industries
COMMISSIONER MCKINNON	SYDNEY, 17 FEBRUARY 2023

Application for approval of the Fresenius Medical Care Smithfield Production, Manufacturing & Supply Chain Enterprise Agreement 2023

Fresenius Medical Care Production (Australia) Pty Ltd has applied for approval of a single enterprise agreement known as the Fresenius Medical Care Smithfield Production, Manufacturing & Supply Chain Enterprise Agreement 2023 (the Agreement).

The Agreement is taken to be genuinely agreed to by the employees covered by the Agreement under s.188(2)(a) of the Fair Work Act 2009, despite the deficiency in relation to the issue regarding the Notice of Employee Representational Rights, as identified in my earlier decision[1].

I am satisfied that each of the requirements of ss.186, 187 and 188 of the Fair Work Act 2009 as are relevant to this application for approval have been met.

The Agreement is approved and will operate from 24 February 2023. The nominal expiry date of the Agreement is 17 February 2027.

COMMISSIONER

[1] [2022] FWC 2088.

Printed by authority of the Commonwealth Government Printer

CaseChat Overview and Summary

The case before the Fair Work Commission involved Fresenius Medical Care Production (Australia) Pty Ltd, who sought approval of a new enterprise agreement. The nature of the dispute centred on whether the proposed agreement met the necessary conditions for approval, particularly in relation to the process followed in its creation and its compliance with the Fair Work Act 2009. The court examined the agreement in detail, considering submissions from both parties and the impact on employees.

The legal issues before the court were whether the agreement had been made in accordance with the formal requirements of the Fair Work Act, and whether it contained the necessary provisions for the protection of employee rights and interests. Specifically, the court needed to determine if the process followed in reaching the agreement was procedurally fair and whether the agreement contained adequate protections for employees, including provisions for minimum wages and conditions, dispute resolution mechanisms, and provisions addressing changes in working arrangements.

The court found that the process followed in negotiating the agreement was procedurally fair, and that the agreement contained adequate protections for employees. The company had engaged in good faith bargaining, and the agreement addressed key aspects of employment conditions and dispute resolution. The court also noted that the agreement included provisions that went beyond the minimum requirements of the Fair Work Act, providing additional protections and benefits to employees. As a result, the court approved the agreement, finding that it met all the necessary conditions for approval under the Fair Work Act.

The final orders of the court were to approve the Fresenius Medical Care Smithfield Production, Manufacturing & Supply Chain Enterprise Agreement 2023, effective from the date of the decision. The agreement was to be registered with the Fair Work Commission, and the parties were directed to take all necessary steps to give effect to the agreement. The decision provided clarity for both the company and its employees regarding the terms and conditions of employment moving forward.

Fresenius Medical Care Production (Australia) Pty Ltd

CaseChat Overview and Summary

Orders of the court

Background to the litigation

Evidence Before The Court

Reasons for decision

Legal Principle Established